Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

906 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort.
Steinebrunner N, Sprinzl MF, Zimmermann T, Wörns MA, Zimmerer T, Galle PR, Stremmel W, Eisenbach C, Stein K, Antoni C, Schattenberg JM, Pathil A. Steinebrunner N, et al. Among authors: zimmermann t. BMC Gastroenterol. 2015 Aug 4;15:97. doi: 10.1186/s12876-015-0328-9. BMC Gastroenterol. 2015. PMID: 26239732 Free PMC article.
No beneficial effect of all-trans retinoic acid in previous non-responder patients with chronic hepatitis C: the ATRACTION study, a phase II randomised trial.
Schuchmann M, Kittner JM, Schlaak JF, Klass DM, Eisenbach C, Berg T, Trautwein C, Günther R, Zeuzem S, Gösseringer R, Ehrlich A, Neumann K, Wachtlin D, Sprinzl MF, Zimmermann T, Böcher WO, Galle PR. Schuchmann M, et al. Among authors: zimmermann t. Dig Liver Dis. 2013 Apr;45(4):323-9. doi: 10.1016/j.dld.2012.11.006. Epub 2012 Dec 13. Dig Liver Dis. 2013. PMID: 23245590 Clinical Trial.
Early changes in dynamic biomarkers of liver fibrosis in hepatitis C virus-infected patients treated with sofosbuvir.
Bernuth S, Yagmur E, Schuppan D, Sprinzl MF, Zimmermann A, Schad A, Kittner JM, Weyer V, Knapstein J, Schattenberg JM, Wörns MA, Galle PR, Zimmermann T. Bernuth S, et al. Among authors: zimmermann t, zimmermann a. Dig Liver Dis. 2016 Mar;48(3):291-7. doi: 10.1016/j.dld.2015.09.015. Epub 2015 Oct 3. Dig Liver Dis. 2016. PMID: 26514736 Free article.
Risk factors in patients with rapid recurrent hepatitis C virus-related cirrhosis within 1 year after liver transplantation.
Zimmermann T, Otto C, Hoppe-Lotichius M, Biesterfeld S, Lautem A, Knaak M, Zimmermann A, Barreiros AP, Heise M, Schattenberg JM, Sprinzl MF, Galle PR, Otto G, Schuchmann M. Zimmermann T, et al. Among authors: zimmermann a. Transplant Proc. 2009 Jul-Aug;41(6):2549-56. doi: 10.1016/j.transproceed.2009.06.120. Transplant Proc. 2009. PMID: 19715972
906 results